Follow on Google News News By Tag * DNA * Ligase * Ligation * Trilink * Grant * Oligonucleotide * Oligo * Sbir * Phase Ii * Snp Detection * Sequencing By Ligation * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | TriLink Awarded SBIR Phase II Grant: Chemical Determinants of DNA Ligase FidelityThe National Institutes of Health recently awarded TriLink BioTechnologies, Inc. (TriLink) a Phase II SBIR Grant of approximately $725,000 to continue their work on developing reagents to enhance the specificity of DNA ligase.
Dr. Natasha Paul, lead biologist, commented, “This grant demonstrates TriLink’s continued focus on solving molecular biology problems through chemistry.” TriLink’s CEO, Richard Hogrefe stated, “TriLink is first and foremost a research and development team. We are committed to our science, as well as supporting our customers’ scientific advancements, and are confident we will soon offer a number of novel ligation products to compliment our CleanAmp™ PCR line of products.” # # # TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the diagnostic and OEM markets. In addition, custom chemistry, contract research services and ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 85 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email info@trilinkbiotech.com, or visit our web site at www.trilinkbiotech.com. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|